Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plexin-A receptors are a family of large transmembrane cell surface receptors that serve as the main signaling receptors for the semaphorin family of proteins. The family consists of four members in humans: Plexin-A1, Plexin-A2, Plexin-A3, and Plexin-A4. These receptors possess an extracellular Sema domain (for ligand binding) followed by alternating PSI and IPT domains, and a highly conserved intracellular region with a split GTPase-activating protein (GAP) domain separated by a Rho-GTPase binding domain (RBD). Upon binding semaphorin ligands, often with the involvement of neuropilin co-receptors, they transduce signals critical for neuronal axon guidance, immune cell regulation, angiogenesis, and cell migration. Their signaling involves changes in small GTPase activity and is tightly controlled through autoinhibition and activation mechanisms. Plexin-A signaling is implicated in cancer progression, nervous system development, inflammation, and vascular biology. No approved clinical drugs directly target Plexin-A receptors, and therapeutic modulation poses risks due to their broad roles in development and tissue homeostasis.
Modulation of semaphorin-plexin signaling (ligand binding triggers conformational changes and signal transduction). Regulation of intracellular GTPase signaling via GAP domain, affecting small GTPases (e.g., Ras, Rho, Rap). Downstream modulation of cytoskeletal and adhesive machinery, impacting cell migration, axon guidance, and immune response.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plexin-A receptor (Plexin-A).